The major phospholipid present in most eukaryotic membranes is phosphatidylcholine (PC), comprising~50% of phospholipid content. PC metabolic pathways are highly conserved from yeast to humans. The main pathway for the synthesis of PC is the Kennedy (CDP-choline) pathway. In this pathway, choline is converted to phosphocholine by choline kinase, phosphocholine is metabolized to CDP-choline by the rate-determining enzyme for this pathway, CTP:phosphocholine cytidylyltransferase, and cholinephosphotransferase condenses CDP-choline with diacylglycerol to produce PC. This Review discusses how PC synthesis via the Kennedy pathway is regulated, its role in cellular and biological processes, as well as diseases known to be associated with defects in PC synthesis. Finally, we present the first model for the making of a membrane via PC synthesis.
The lipid bilayer is a complex assembly of over 1000 distinct molecules constantly undergoing constitutive and agonist-stimulated synthesis and turnover, while at the same time maintaining the appropriate physical properties to act as an effective permeability barrier. Phospholipids are the main components of biological membranes while simultaneously serving as (a) second messenger molecules, (b) receptors for the recruitment of specific proteins to membranes, (c) chaperones to aid in protein folding, and (d) direct modulators of protein function [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . Indeed,~30% of all proteins are integral membrane proteins while another~30% are thought to function at a membrane surface [13, 14] . Thus, altering the phospholipid composition of a particular cellular membrane can have dramatic effects on biology.
Phosphatidylcholine (PC) is the major phospholipid present in eukaryotic cells, comprising~50% of phospholipid mass in most cell types [15] . PC is composed of a glycerol backbone to which two fatty acids are attached at the sn-1 and sn-2 positions and a phosphocholine moiety at the sn-3 position (Fig. 1) . PC is not a single molecule but is a group of molecules that differ through the types of fatty acids attached to the glycerol backbone that are united by the choline head group. Most fatty acids are attached to the glycerol backbone through an ester linkage; however, some fatty acids can be linked through ether or vinyl ether bonds. These latter two types of linkages are found in specialized versions of PC such as platelet-activating factor and plasmalogens. This review will focus on the roles of the major ester linked form of PC.
As the major phospholipid in cell membranes PC has a housekeeping role in maintaining membrane integrity. PC also has specific functions in cellular and human physiology. Increased cell growth is accompanied by an increase in PC synthesis, and monitoring Kennedy pathway metabolites by positron emission tomography is a diagnostic used for several cancers Abbreviations DAG, diacylglycerol; ER, endoplasmic reticulum; MOE, Molecular Operating Environment; PC, phosphatidylcholine; PI, phosphatidylinositol; PPAR, peroxisome proliferator activator receptors; UAS, upstream activation sequence; VLDL, very low density lipoprotein. [16, 17] . PC is required for very low density lipoprotein (VLDL) secretion from hepatocytes [18] and myelination of nerves [19] [20] [21] [22] [23] [24] . PC is also metabolized to generate the second messengers, diacylglycerol (DAG) and phosphatidic acid, as well as arachidonic acid/prostaglandins/leukotrienes involved in inflammation and asthma [15] , and the osmolyte glycerophosphocholine [25] [26] [27] [28] . In addition, specific fatty acyl species of PCs are essential components of pulmonary surfactant in lungs and as ligands for cellular receptors [29] [30] [31] .
Roles of PC acyl chain specificity in cellular and human biology
Most PC molecules have fatty acyl chains ranging from 14 to 26 carbons in length, with the majority being 16 or 18 carbons long. PC molecules with shorter fatty acyl chains have less surface area for stabilization by neighboring hydrophobic fatty acids via van der Walls interactions, and thus are less stiff and viscous than longer acyl chain PCs [4, 11] . The number of double bonds (saturated vs unsaturated) in each fatty acid alters the shape of the fatty acid, which in turn can alter the biophysical properties of the membrane (Fig. 1) . A fatty acid with no double bonds results in a less fluid but thicker membrane. The introduction of double bonds results in kinks in the fatty acyl chain which decreases membrane rigidity and makes it more difficult for fatty acids to pack tightly together. The introduction of various fatty acyl chains into PC is via a combination of the acyl specificity of biosynthetic enzymes, and subsequent remodeling of PC through the action of phospholipases/acyltransferases and transacylases [15, 32] . The importance of fatty acyl chain length and type has been demonstrated in yeast cells where the response to a steady decrease in PC content was an increase in shorter and more saturated fatty acyl chains into PC [33-36] to maintain membrane fluidity and bilayer propensity.
The fatty acyl specificity of PC is also known to play a major role in several biological processes in humans indicating that not all PCs have similar functions. Probably the best characterized role of specific PC fatty acyl species is in the synthesis of lung surfactant. PC contributes to 80% of the composition of lung surfactant, with 60% of this PC containing a saturated fatty acid at each position. The major species is 16:0/16:0 PC which comprises 60% of lung surfactant PC, followed by 16:0/16:1 PC at 30% with the remaining 10% mainly consisting of 16:0/14:0 PC. Other lipids as well as four surfactant proteins, SP-A, SP-B, SP-C, and SP-D, make up the remainder of surfactant [29, 31] . Lung surfactant is secreted by alveolar cells of the lung where it acts to reduce surface tension on alveolar structures to enable lungs to expand and contract. In the absence of surfactant production, such as during neonatal respiratory distress syndrome experienced by premature infants, the high level of surface tension results in pulmonary edema due to an accumulation of intra-alveolar fluid and a decrease in gas exchange by the lung [29] . Acute and chronic adult conditions can also be attributed, at least in part, to a decrease in lung surfactant synthesis and include pneumonia, sepsis, cystic fibrosis, chronic obstructive lung diseases, asthma, and the inhalation of tobacco smoke [29] . Lung surfactant production is stimulated by several hormones including glucocorticoids, thyroid hormones, and estrogen, while androgens and insulin decrease surfactant PC production. Genetic diseases also reduce surfactant production, with current genes encoding surfactant proteins and the phospholipid transporter ABCA3 [29] . More precise mechanisms of regulation of surfactant production still need to be determined at the level of PC synthesis, fatty acyl chain remodeling, and secretion from alveolar cells [31] .
The fatty acyl chain type of PC appears to affect the regulation of VLDL secretion from the liver. PCs containing more polyunsaturated fatty acids at the sn-2 position are thought to establish a more suitable (fluid) environment to enable more efficient incorporation of apoB into VLDL [18, 37] .
Recently, specific fatty acyl species of PC have been determined to be ligands for peroxisome proliferator activator receptors (PPARs). PPARs are nuclear receptors that regulate gene transcription that bind hydrophobic ligands. The 16:0/18:1 PC species appears to be the endogenous ligand for PPARa, which in turn regulates transcription of a plethora of lipid-metabolizing enzymes [30] . Indeed, hepatic portal vein injection of 16:0/18:1 PC into mice resulted in an increase in PPARa-mediated gene expression and a decrease in hepatic steatosis. PPARd controls gene expression for proteins required for fatty acid uptake and b-oxidation by muscle, and it was determined to be bound by 18:0/18:1 PC and regulated by 18:0/18:1 PC serum level [30] .
It is clear that not all PC species are made equal. Fatty acyl chain specificity can alter the biophysical, biochemical, and signaling properties of PC. Changes to PC fatty acyl groups enable cellular membranes to maintain permeability barriers in the presence of cell stressors, while simultaneously enabling PC to act as a source for specific signaling pathways. Specific fatty acyl species of PC are required for surfactant production in the lung, for the incorporation of lipoproteins into VLDL particles in the liver, and as specific ligands for intracellular receptors that in turn regulate global lipid metabolism. Much more research is required to delineate the likely myriad functions of the hundreds of fatty acyl versions of PC found in cellular membranes.
PC synthesis: Insights from yeast
The yeast Saccharomyces cerevisiae has been instrumental in our understanding of phospholipid metabolism. Indeed,~80% of genes encoding the major phospholipid metabolic enzymes in humans were first identified in S. cerevisiae, and then by expression cloning or more recently by genome comparisons, the corresponding human genes/proteins were identified and characterized [38] [39] [40] [41] . Comparisons of the primary sequences of yeast and mammalian proteins (as well as their predicted protein secondary structures) have revealed significant levels of homology with especially high levels of conservation in regions predicted to lie in active sites [42] [43] [44] [45] [46] . Lipid activation properties of yeast and mammalian enzymes also reveal a high level of similarity [6, 7, 38, 41, 47] , implying that controls regulating the maintenance of phospholipid homeostasis are likely conserved.
The facility of genetic screens, including highthroughput roboticized screens and the capacity to rapidly generate precise gene deletions or replacements in S. cerevisiae, have facilitated a rapid progression in determining how altering phospholipid metabolic steps affects specific cellular functions [5, 8, 48] . Through yeast genetics screens, the Kennedy pathway for PC synthesis in yeast has been implicated in the regulation of vesicular trafficking [48] [49] [50] .
A genetic screen in the yeast S. cerevisiae determined that inactivation of any of the three enzymes of the Kennedy pathway for PC synthesis (Fig. 2) [49] [50] [51] [52] . The major phenotype associated with loss of Sec14 function is a dramatic decrease in the function of essential trans-Golgi vesicular trafficking pathways [48] . It is currently believed that Sec14 acts as a sensor of membrane phospholipid composition that in turn regulates PC and phosphoinositide metabolic pathways to provide the appropriate lipid environment for vesicular transport to occur. In vivo regulation of PC metabolism by Sec14 is evident as Sec14 inhibits PC synthesis [10] , while a decrease in Sec14 function increases the rate PC turnover by the PC-phospholipase D Spo14 while simultaneously decreasing PC turnover by the PC-phospholipase B Nte1 [28, [52] [53] [54] [55] . In cells with diminished Sec14 function, inactivation of the SPO14 gene further aggravated growth and vesicular transport defects [56, 57] , whereas increased expression of NTE1 increased growth rate [54] . Later work in mammalian cells determined that inhibition of PCYT1A activity could restore vesicular trafficking in cells deficient in the PC/PI transfer protein Nir2 [58] . Although Sec14 clearly regulates PC metabolism, and integrates PC metabolism with vesicular trafficking from the trans-Golgi, the mechanism by which PC metabolism is regulated and integrated with Sec14 function is still unclear.
The Kennedy pathway
The pathway for the synthesis of PC was elucidated by Eugene Kennedy and colleagues in the late 1950s and early 1960s [59] . The Kennedy pathway is essentially the sole de novo pathway for PC synthesis in all eukaryotic cell types, except for yeast and the mammalian liver where PE methylation also contribute to PC synthesis [60] [61] [62] [63] . Choline is taken up by cells and subsequent PC synthesis through the Kennedy pathway is a three-step enzymatic process (Fig. 2) The synthesis of PC through the CDP-choline pathway is essential for cell viability. Shifting a Chinese hamster ovary cell line with a temperature-sensitive allele of PCYT1A (the main isoform of CTP:phosphocholine cytidylyltransferase in this cell type) to the nonpermissive temperature resulted in the induction of apoptosis. This effect was demonstrated to be specific to loss of function of PCYT1A activity as cell growth could be rescued by plasmid-borne expression of normal PCYT1A [62, 68] . Similar studies performed in yeast indicated that loss of Pct1 function in a yeast strain where the Kennedy pathway was the sole route available for PC synthesis also resulted in cell death [33] [34] [35] 65 ]. These results indicate that PC has an essential role in cell viability that cannot be substituted for by other cellular phospholipids.
The following sections outline the genes/proteins that comprise the Kennedy pathway for PC synthesis and their regulation. The role of each gene/protein in disease is also detailed when known.
Choline uptake
Choline is required to initiate the Kennedy pathway. Choline can be supplied exogenously to cells, or via the diet to mammals, as well as recycled within cells upon PC catabolism [15, 28] . Choline uptake by yeast cells is by the high-affinity Hnm1 choline transporter [69] , while in human cells choline is taken up by a high-affinity CHT1 transporter (also known as SLC5A7), an intermediate-affinity CTL1 transporter (also known as SLC44A1), and low-affinity organic cation OCT family transporters [18, 70] . The primary function of CHT1 is not for PC synthesis, but instead is for acetylcholine synthesis in cholinergic neurons. The CTL1 transporter is believed to be the main transporter for choline used for PC synthesis. Mutations in the CTL1 gene are thought to cause orthostatic tachycardia syndrome in humans [70] .
Regulation of the choline transport for PC synthesis
The Hnm1 high-affinity choline transporter in yeast is the sole choline transporter in this organism, as disruption of the HNM1 gene completely abolishes choline transport into the cell [69] . Interestingly, a pronounced reduction in choline transport activity is observed in yeast cells grown in choline-rich medium. Upon choline exposure, the Hnm1 protein is endocytosed and degraded by the vacuole (the yeast equivalent of the lysosome) [69] . The integrity of the Kennedy pathway is not necessary for choline to elicit Hnm1 degradation suggesting the rate of PC synthesis itself does not regulate Hnm1 stability, instead, the major driver of Hnm1 degradation is choline transporter rate. Hnm1 endocytosis and vacuolar targeting require the casein kinase 1 pair Yck1/Yck2 and the ubiquitin ligase Rsp5 [69] . It is currently thought that Yck1/Yck2 phosphorylates Hnm1 targeting it for ubiquitination by Rsp5 for subsequent endocytosis and delivery to the vacuole for degradation.
The majority of choline transported into mammalian cells for use in PC synthesis appears to be by the CTL1 transporter [18] . In fibroblasts isolated from orthostatic tachycardia syndrome patients, where there was a 70% reduction if CTL1 mRNA, there was a 60% reduction in choline uptake and rate of PC synthesis [70] . The addition of choline to the medium increased CTL1 level and PC synthesis indicating that the level of the CTL1 transporter is controlled by substrate availability [70] . This observation also points to the use of choline supplementation as a possible therapy for orthostatic tachycardia syndrome patients with CTL1 mutations.
Choline kinase
Choline kinase is the first enzymatic step in the synthesis of PC. Choline kinase converts choline and ATP to phosphocholine and ADP. In yeast, there is a sole choline kinase encoded by CKI1, while in humans there are two choline kinase-encoding genes, CHKA and CHKB (often referred to as CKa and CKb) [40, 43, 71] . CHKB expression appears to be more ubiquitous than CHKA. Choline kinases are soluble proteins found in the cytoplasm that contain a conserved phosphotransferase motif involved in catalytic function. The crystal structure of a choline kinase from Caenorhabditis elegans reveals that the catalytic site is similar to protein kinases despite little similarity at the amino acid sequence level [43] . The structure suggests that ATP binds in a pocket formed by highly conserved and catalytically important residues. The choline kinase catalytic site is composed of several flexible loops, with choline and ATP binding in adjacent pockets.
The yeast Cki1 protein appears to be highly specific for the use of choline as a substrate as inactivation of the CKI1 gene ablates choline kinase activity in vitro and in vivo [72] [73] [74] . Interestingly, the two human choline kinase isoforms can also use ethanolamine as a substrate in vitro [18] .
In humans, an increase in choline kinase activity, primarily due to CHKA, is seen in human breast, lung, prostate, and colorectal human cancers, and determining the level of choline-containing Kennedy pathway metabolites is used as a diagnostic for some [46, 77, 78, 81] . The transcription of CKI1 is also regulated by zinc. Zinc depletion results in a concentration-dependent induction of CKI1 expression. This regulation is mediated by the zinc-sensing transcriptional activator Zap1 [82] . Zap1 interacts with two UAS zinc responsive element sequences in the CKI1 promoter to induce CKI1 expression. The induction of CKI1 expression in zinc-depleted cells results in increased choline kinase activity in vitro and in vivo resulting in an increase in PC synthesis via the Kennedy pathway. Yeast Cki1 is known to be regulated by phosphorylation at several Ser residues. Protein kinases A and C are known to phosphorylate some of these Ser residues [72] [73] [74] . Protein kinase A phosphorylates Cki1 on two sites, while protein kinase C is known to phosphorylate one site. Phosphorylation of Cki1 by protein kinase A decreases phosphorylation by protein kinase C; however, the converse is not true. Phosphorylation of Cki1 by either protein kinase A or C increases choline kinase enzymatic activity in vitro and increases the rate of synthesis of PC via the Kennedy pathway in vivo [78] .
Phosphorylation of human CHKA has been reported to enhance its catalytic activity and concomitantly elevate the synthesis of PC via the Kennedy pathway. Phosphorylation of human CHKA occurs at a tyrosine located in the choline-binding groove in its phosphoryltransferase motif. The phosphorylation of CHKA is cSrc-dependent [83] , and induces the interaction of CHKA with the EGFR resulting in the translocation of CHKA from the cytosol to the plasma membrane. Treatment of cells with EGF increases the proliferation of cells transfected with wild-type CHKA, but not cells transfected with CHKA devoid of PKA phosphorylation sites, consistent with a role for CHKA activity driving tumor cell growth.
Similar to the yeast enzyme, human CHKB is phosphorylated on Ser residues near its N terminus by protein kinase A [84] . The phosphorylated residues identified in both human CHKB and yeast Cki1 are not located in the catalytic domain, yet still increase enzyme activity, implying an allosteric mechanism of regulation. Some reports have indicated that CHKB can also phosphorylate ethanolamine, and interestingly protein kinase A phosphorylation of CHKB significantly increased activity toward choline while not affecting activity toward ethanolamine [84] . This implies that CHKB phosphorylation may be a mechanism to regulate its activity between PC and PE synthesis.
CTP:phosphocholine cytidylyltransferase -the ratedetermining enzyme in the synthesis of PC
The conversion of phosphocholine and CTP to CDPcholine and pyrophosphate by CTP:phosphocholine cytidylyltransferase is the rate-determining step for PC synthesis. The enzyme is encoded by the PCYT1A and PCYT1B genes in mammals [2,65, [85] [86] [87] [88] [89] , and the PCT1 gene in yeast [60, 65] . PCYT1A expression is ubiquitous while PCYT1B is found in limited tissues. A global knockout of Pcyt1a in mice is embryonic lethal [90] . To enable insight into the roles of Pcyt1a, organ-and cellspecific Pcyt1a knockout mice have been generated. A lung-specific Pcyt1a knockout resulted in neonatal respiratory failure due to an inability to synthesize PC for the production of lung surfactant [31] , whereas a knockout of Pcyt1a in macrophage resulted in macrophage that were more susceptible to cholesterolmediated cell death [91] . A liver-specific Pcyt1a knockout resulted in a gender-specific difference in hepatic lipid metabolism. Female mice displayed a decrease in PC level along with impaired VLDL secretion and triacylglycerol accumulation in the liver [37]; these changes were not apparent in male mice. When the liver-specific Pcyt1a knockout mice were fed a high-fat diet, both sexes displayed the hallmarks of nonalcoholic fatty liver disease including an increase in TAG metabolism as well as release of alanine aminotransferase from the liver into the circulation (indicative of liver damage). In humans, point mutations in the PCYT1A gene have been found to cause congenital fatty liver disease with lipodystrophy [92] . One of the alleles associated with congenital fatty liver disease has a deletion of Glu280. The Glu280 amino acid residue lies in the amphipathic helix of PCYT1A, which is important for PCYT1A to associate with membranes and become enzymatically active. The Glu280 mutation was found to both decrease PCYT1A expression in cells from lipodystrophy patients, and result in less PCYT1A protein bound to membranes in cells. Other mutations identified in patients contained point mutations adjacent to the catalytic domain, or within the Ser-Pro-rich C-terminal region that are predicted to result in a longer protein being synthesized. Mutations in human PCYT1A have also been shown to be causal for a spondylometaphyseal dysplasia with cone-rod dystrophy [93] [94] [95] . A recent study found that specific alleles of PCYT1A were responsible for a retinal dystrophy without signs of skeletal dysplasia or metabolic or hepatic alterations [96] . As the Pcyt1a knockout in mice is embryonic lethal, and none of the mutations in human patients are predicted to completely ablate protein function, it is likely that these inherited diseases are due to a decrease in PCYT1A function.
Mice with a global Pcyt1b knockout are viable but display gonadal dysfunction and impaired fertility [88, 97] . In cultured neuronal cells, knockdown of Pcyt1b decreased neuronal branching [19, 20] . Based on the mouse and human phenotypes observed upon decreased expression of either PCYT1A or PCYT1B, the two isoforms of PCYT1 have different functions in different tissues.
Regulation of CTP:phosphocholine cytidylyltransferase
As the rate-determining step in the Kennedy pathway for PC synthesis, CTP:phosphocholine cytidylyltransferase is by far the most well studied of the enzymes within this pathway. Specific insights from work on yeast Pct1 include its inhibition by the PC/PI transfer protein Sec14 as a means to link regulation of PC synthesis with transGolgi vesicular trafficking [10,48,51,52,54,57]. It is not known if a mammalian Sec14 family member inhibits CTP:phosphocholine cytidylyltransferase activity. Most of the work on the regulation of CTP:phosphocholine cytidylyltransferases has been performed on mammalian PCYT1A.
Mammalian PCYT1A/B and yeast Pct1 are amphitropic enzymes, meaning that they bind to membranes and are active when membrane bound. There is a 30-to 50-fold increase in catalytic efficiency for PCYT1A when membrane bound [4] . The enzymes do not bind a particular lipid but instead bind to membranes that are loosely packed [2-4,11,12,98-101]. Many of the lipids that result in loosely packed membranes are catabolites of PC including phosphatidic acid, DAG, and fatty acids. This has resulted in the hypothesis that this form of regulation allows cells to regulate PC synthesis in a manner that ensures membrane permeability is maintained. Membrane binding by CTP: phosphocholine cytidylyltransferases is via a long amphipathic a-helix (M domain) located C-terminal to the catalytic domain. The M domain is auto-inhibitory when the enzyme is soluble, and upon membrane binding, the axis of the M domain rotates to lie parallel to the membrane to release the catalytic site [3,4,11,98,99]. As an example of membrane binding in a biological context, in mammalian cells there is an increase in PC synthesis in S phase due to an increase in PCYT1A translocation to membranes to activate the enzyme to generate membrane required for cell division [15, 63, 65, 89, 98, 102] .
PCYT1A and B are also highly phosphorylated; however, the role of phosphorylation in the regulation of PCYT1 activity is still unclear. Phosphorylation of PCYT1A and PCYT1B occurs in a Ser-Pro enriched region at their C-terminal end making them candidates for proline-directed kinases [103, 104] . When this domain is eliminated from PCYT1A, there are no other phosphorylations detected implying all phosphorylation occurs in this domain. Initial studies showed that the addition of oleic acid or phospholipase C (to generate DAG) resulted in dephosphorylation of PCYT1 and translocation of PCYT1 to membranes, this could be blocked by the addition of the protein phosphatase 1/2a inhibitor resulting in PCYT1 phosphorylation and its movement to the cytosol [105, 106] . Thus, PCYT1 phosphorylation initially appeared to regulate PCYT1 membrane binding, and hence activity. However, changes in PCYT1 phosphorylation have not always been associated with changes in membrane binding. Indeed, changing every Ser that is phosphorylated in PCYT1A to Ala to mimic the dephosphorylated enzyme, or Glu to mimic the fully phosphorylated enzyme, did not appreciably affect the rate of PC synthesis in Chinese hamster ovary cells carrying a temperature-sensitive allele of PCYT1A [64, 103, 104] . Paradoxically, the Ser to Ala dephosphorylation mimic was found primarily associated with membranes using subcellular fractionation [104] . Cells expressing these PCYT1A phosphomutants were also prevented from undergoing apoptosis, which is their terminal phenotype when grown at the nonpermissive temperature for the temperature-sensitive allele of PCYT1A [64, 103, 104] . The role of phosphorylation may be to fine tune membrane binding to membranes, possibly those with high anionic lipid content [4, 98] ; however, this is still a hypothesis that requires further validation.
Another potential form of regulation for PCYT1A, as well as yeast Pct1, is translocation from the cytoplasm to the nucleus [65, 85, 87, 102, [107] [108] [109] . Both proteins have a nuclear localization sequence in the N terminus of the protein. Interestingly, for both PCYT1A and Pct1, removal of the nuclear localization signal and expression of these variants in cells devoid of endogenous PCYT1A/PCT1 did not affect the rate of PC synthesis by the Kennedy pathway [44, 65, 107, 108] . It has been noted that PCYT1A is localized to the nucleus in only certain cells including many primary and immortalized cell lines. However, in cells where there is a large need for PC synthesis such as pulmonary epithelial cells, or cells that have rapidly proliferating membranes such as differentiating B cells, PCYT1A is present in the cytoplasm instead of the nucleus [15] . Regardless of localization, the addition of membrane activators such as oleic acid result in translocation of nuclear localized PCYT1A to the nuclear membrane, and cytoplasmic PCYT1A to the ER, which results in an increase in the rate of PC synthesis. Interestingly, a noncatalytic role for PCYT1A has been observed within the nucleus in response to lipid activators. Increased expression of PCYT1A results in an increase in the formation of nuclear membrane invaginations known as nuclear tubules [85, 87, [109] [110] [111] . Interestingly, catalytically inactive PCYT1A could also induce nuclear tubule formation, and an engineered version of PCYT1A with changes to the M domain that increased membrane binding increased nuclear tubule formation. In vitro studies have shown that the M domain can remodel lipid vesicles into tubules [4, 12] . Nuclear tubules are thought to play a role in cytoplasm-nuclear communication, or possibly chromatin reorganization. Defining the biological role of PCYT1A in the generation of nuclear tubules requires further research.
The process that results in CTP:phosphocholine cytidylyltransferase localization to the nucleus was elucidated in yeast where it was determined that the karyopherin Kap60 (also known as Srp1 and importin-a) directly interacts with Pct1 [44] . Kap60 and Kap95 (Rsl1/importin-b) form a heterodimer that regulates protein import into the nucleus. Diminution of the function of either Kap60 or Kap95 abolished Pct1 nuclear import. A bipartite basic region in Pct1 was required for Pct1 to interact with Kap60 and for its import into the nucleus. Interestingly, the rate of PC synthesis through the CDP-choline pathway was normal when Pct1 import into the nucleus was prevented by decreasing Kap60 function; however, diminishing Kap95 function resulted in almost complete ablation of PC synthesis via the CDP-choline pathway [44] . Why Pct1 is nonfunctional in cells lacking Kap95 function has not been determined. PCYT1A also interacts with an importin-a, and monoubiquitination of a Lys adjacent to the nuclear localization signal of PCYT1A resulted in its cytoplasmic retention and degradation [107] .
PCYT1A has been observed to also exit the nucleus [102] . There is no clear nuclear export signal present in PCT1A or yeast Pct1, and although it has been observed that deletion of the M domain from PCYT1A impaired nuclear export [110] , the mechanism of nuclear export is not known. Upon exit from G 0 to the G1 phase of the cell cycle, there is export of PCYT1A from the nucleus to the ER and an accompanying increase in PC synthesis as cells resume growth [102] . Export of the PCYT1A Drosophila homologs Cct1 and 2 from the nucleus to lipid droplets in the cytoplasm was observed upon treatment of cells with the fatty acid oleate [112, 113] . Lipid droplets contain a core rich in triacylglycerol covered by a monolayer of PC. Diminution of Drosophila Cct protein levels resulted in larger yet fewer lipid droplets. It is thought that translocation of Drosophila Cct from the nucleus to lipid droplets when faced with excess fatty acid is required to provide extra PC to cover the enlarged surface area when lipid droplet synthesis is increased. Interestingly, in various mammalian cells, there was no evidence of translocation of PCYT1A to lipid droplets upon oleate addition, including mammalian adipocytes [114] .
Although CTP:phosphocholine cytidylyltransferases are mainly regulated post-translationally, transcriptional regulation has been reported for PCYT1A. PCYT1A expression has been observed to be regulated in response to cell growth and development. PCYT1A expression is increased during the S phase of the cell cycle, by colony-stimulating factor 1, and by liver regeneration [18, 89, 115, 116] . The study of Pcyt1a expression in mice revealed that the promoter lacks a TATA box and contains Sp1B, Sp1C, Sp3, TEF4, Ets-1, and Rb binding elements. Sp1 and Sp3 increase transcription of Pcyt1a during the S phase of the cell cycle via a process that is enhanced by phosphorylation of Sp1 with Cdk2 [115, 117] . Sp1 is a coactivator for Rb and Ets-1 transcription of Pcyt1a, whereas the Ets-1-like protein Net represses Pcyt1a expression. HRas-transformed fibroblasts display increased Pcyt1a expression via a process that requires increased phosphorylation of Sp3. How phosphorylation of these transcription factors integrates Pcyt1a/PCYT1A transcription with cell growth signals is an important area that requires further research to delineate mechanism. The expression of human PCYT1A is also regulated by the transcription factor XBP-1. XBP-1 activity is increased by induction of the unfolded protein response, and other processes that require ER expansion such as B-cell proliferation and class switching [86, 118] . XBP-1 increases the expression of lipids known to increase PCYT1A activity, such as fatty acids. Thus, XBP-1 regulation of PCYT1 activity appears to be via the ability of XBP-1 to increase the level of fatty acids, which in turn increase PCYT1A activity directly via increased PCYT1A binding to membranes.
The regulation of the rate-determining step in PC synthesis is complex. Much understanding of the mechanisms of CTP:phosphocholine cytidylyltransferase activity has been elucidated. Outstanding questions include determining the role of phosphorylation, transcriptional regulation, and nuclear localization in cellular and organismal biology. The precise manner in which different point mutations in PCYT1A can cause genetic diseases, congenital fatty liver disease with lipodystrophy, spondylometaphyseal dysplasia with cone-rod dystrophy, and retinal dystrophy, would shed light on how different types of misregulation of CTP: phosphocholine cytidylyltransferase activity cause various human diseases.
Cholinephosphotransferase -the making of a membrane
The terminal step in the synthesis of PC is via the action of cholinephosphotransferase which transfers phosphocholine from CDP-choline onto DAG to produce PC and CMP. In yeast and mammals, there are two genes known that code for a cholinephosphotransferase (CPT1 and CEPT1 in humans and CPT1 and EPT1 in yeast) [6, 38, 41, 47] . CPT1/Cpt1 are specific for CDP-choline, whereas CEPT1/Ept1 can use both CDP-choline and CDPethanolamine in vitro and in cells [6, 38, 41, 60, 61] . The need for two cholinephosphotransferases is not entirely clear; however, immunolocalization of CPT1 indicates a primarily Golgi localization while CEPT1 is primarily present in the ER [47] . Knockout of either the CPT1 or EPT1 gene in yeast individually resulted in a decrease in the rate of PC synthesis from 60% to 95% in CPT1 null cells, and 5-40% in EPT1 null cells, depending on the yeast strain background used, indicating that both enzyme do have the capacity to synthesize PC in vivo [6, 47, 60, 61] . Expression of human CPT1 and CEPT1 in yeast cells devoid of both CPT1 and EPT1 genes restored PC synthesis to wild-type levels indicating that both human enzymes have the capacity to synthesize PC [38, 41] . In yeast and mammalian cells, metabolism of a Golgi-specific pool of PC has been implicated in the regulation of vesicle transport from this organelle [48, 52, 56] . It had been observed that inactivation of the yeast CPT1 gene in conjunction with an inactivated SEC14 gene restored Golgi transport, but inactivation of the yeast EPT1 gene did not (23, 45) . This indicates that the two cholinephosphotransferases that synthesize PC in yeast are not equal with respect to their cell biological functions. It will be interesting to determine if other cell biological functions are specifically regulated by the two different enzymes that catalyze the terminal step in the synthesis of PC.
A muscle-specific knockout of Cept1 was constructed, and when these mice were fed a high fat diet, they displayed increased insulin sensitivity and exercise intolerance. Muscle cells from these mice display altered sarcoplasmic reticulum Ca 2+ -ATPase-dependent Ca 2+ uptake, and activation of Ca 2+ signaling pathways known to improve insulin sensitivity [119] . In humans, surgery-induced weight loss results in a decrease in skeletal muscle CEPT1 mRNA level, and CEPT1 mRNA level has been observed to inversely correlate with insulin sensitivity [119] . Thus, there may be a specific role for the synthesis of PC by CEPT1 in the ER, or its ability to synthesize both PC and PE, that is necessary for sarcoplasmic reticulum function that impacts Ca 2+ signaling and subsequent insulin sensitivity that cannot be compensated for by CPT1. A third gene has been identified in humans that is specific for the use of CDP-ethanolamine, EPT1. Point mutations in EPT1 that decrease catalytic activity result in a hereditary spastic paraplegia [45] .
Regulation of cholinephosphotransferase activity
Similar to the yeast CKI1 gene, but not PCT1, the CPT1 and EPT1 gene promoters contain an UAS INO that is responsive to the addition of inositol, and whose signal is increased by the addition of choline [60, 67] . It is not clear why the rate-determining step in PC synthesis via the Kennedy pathway is not regulated at a transcriptional level in a manner similar to the first and terminal steps of this pathway. This would be an interesting question to answer as it could provide major insights into how cells sense lipids, and lipid precursors, to maintain membrane permeability barriers.
All cholinephosphotransferase enzymes are integral membrane-bound proteins with 6-7 predicted membrane-spanning domains [6, 38, 41, 47, 61] . A cholinephosphotransferase has yet to be purified to apparent homogeneity. The use of yeast strains devoid of endogenous cholinephosphotransferase activity (inactivated CPT1 and EPT1 genes) has enabled a null background to express the yeast and human enzymes for structure/ function work to be performed. Cholinephosphotransferase enzyme activity requires either Mg 2+ or Mn 2+ for enzyme activity, and is activated by phospholipids with PC being the most efficient activator [6, 38, 41] . As the cholinephosphotransferase reaction is one step downstream of the rate-determining step in the synthesis of PC, we propose that activation of cholinephosphotransferase by PC, the terminal product of the Kennedy pathway, ensures that pathway regulation is not compromised by a block downstream of the major regulatory step. Differences in CDP-alcohol specificity for the yeast Cpt1 and Ept1 enzymes, and the high degree of predicted secondary structure conservation, prompted the use of Cpt1-Ept1 chimeric enzymes to delineate the CDP-aminoalcohol-binding site. The capacity of each chimeric Cpt-1-Ept1 chimera to use only CDP-choline as per Cpt1, or both CDP-choline and CDP-ethanolamine as per Ept1, enabled the CDP-aminoalcoholbinding site to be localized to a soluble region of the protein spanning amino acid residues 79-186 [6,61,66] . Similarly, Cpt1 and Ept1 were found to prefer different DAG fatty acyl species and the Cpt1-Ept1 chimeric enzymes enabled the DAG-binding site to be localized the first three membrane-spanning domains that surround the CDP-aminoalcohol-binding region [6] . Further analysis of this region pointed to a motif that was conserved in all known CDP-alcohol phosphotransferases, AspGlyX 2 AlaArgX 8 GlyX 3 AspX 3 Asp (where X is any amino acid), prompting the hypothesis that these residues comprise a catalytic motif for this class of enzymes [42] . Alanine-scanning site-directed mutagenesis of these residues within Cpt1 pointed to a general base catalysis via a nucleophilic attack of the hydroxyl group of DAG directly on the phosphoester bond of CDP-choline via one of the final two Asp residues of the catalytic motif [42] .
To date, over 12 000 unique CDP-aminoalcohol phosphotransferase motif-containing enzymes have been identified and have pointed to an expanded diagnostic motif for this enzyme class that contains an Asp three residues upstream of the original motif as also being highly conserved [120, 121] . Two enzymes that contain the CDPaminoalcohol phosphotransferase motif, thought to be di-myo-inositol-phosphate phosphate synthases that use CDP-inositol or CDP-glycerol as substrates, have been crystallized from Archaeoglobus fulgidus [120, 121] . The proteins are homodimers with each protomer consisting of distinct domains. The active site of each protomer possesses a novel hydrophobic fold around a polar cavity. Within the active site, the CDP-aminoalcohol phosphotransferase motif is found at the ends of transmembranes two and three. The first three Asp residues within the expanded AspX 3 AspGlyX 2 AlaArgX 8 GlyX 3 AspX 3 Asp face each other across these two transmembrane helices and coordinate the pyrophsophate of CDP. The fourth Asp is likely the catalytic residue. The first Gly allows for flexibility for transmembrane two and is thought to allow the first Asp to orient toward the active site. The Ala and both Gly residues interact with the cytosine ring of CDPcholine and the Arg interacts with the a-phosphate of the CDP moiety.
Using the A. fulgidus di-myo-inositol-phosphate phosphate synthase crystal structure [120, 121] , and proposed catalytic mechanism for CDP-aminoalcohol phosphotransferase motif-containing enzymes [42] , we built a homology model of the active site of human CPT1 using MOLECULAR OPERATING ENVIRONMENT (MOE, Montreal, QC, Canada) software (Fig. 3) . A resolution of 1.956
A over the 124 amino acid residues that encompass the CPT1 catalytic motif was obtained. Two binding pockets were identified: a larger site, comprising 33 amino acids identified as Pocket 1; and a smaller site located deeper in the catalytic pocket comprising 14 amino acid residues identified as Pocket 2. An energy minimized structure of CDP-choline was docked into Pocket 2 via induced fit docking algorithms, allowing for freedom of motion of both the ligand and the amino acid side chains. Induced fit docking of DAG into Pocket 1 was performed with CDP-choline bound in Pocket 2. The results were examined and the top pose for each system was energy minimized with backbone constraints in place for the protein. A final binding pose for the CPT1 catalytic site was identified as an optimal position for both DAG and CDP-choline to undergo catalysis facilitated by the terminal Asp residue within the CDP-aminoalcohol phosphotransferase motif. This is the first proposed structure for a cholinephosphotransferase catalytic motif. Confirmation of this model awaits the purification and crystallization of a cholinephosphotransferase.
Conclusions and perspectives
Roles for specific fatty acyl species of PC in health and disease are being determined, and further roles are likely to emerge. The role of biosynthetic enzymes, vs remodeling enzymes, in maintaining the fatty acyl species of PC requires further investigation. PC synthesis itself is regulated primarily at the post-translational level. Gaps in our knowledge of the regulation of PC synthesis include in-depth protein structure-function studies to more fully understand the biochemical basis for PC synthesis regulation. In addition, each enzyme of the Kennedy pathway is present in a different intracellular location: choline kinase is cytoplasmic; CTP:phosphocholine cytidylyltransferase is cytoplasmic and nuclear and translocates to ER and nuclear membranes to become active; cholinephosphotransferases are found in the ER and the Golgi. Are the soluble metabolites of the Kennedy pathway channeled to enable efficient and coordinated regulation of PC synthesis, or does simple metabolite diffusion enable PC synthesis by these enzymes? If the former, how are the Kennedy pathway metabolites channeled to each subsequent enzyme in the pathway? As the genetic cause of more inherited diseases is revealed, roles for specific Kennedy enzyme isoforms in human biology will be revealed. This is also true via the use of tissue-and cell-specific mouse knockouts for genes encoding Kennedy pathway enzymes. Further generation of the precise genetic mutations in mice of the diseases causing alleles found in humans will also enable a much deeper understanding of the roles of each Kennedy pathway enzyme in human health and disease. 
